A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through Menopause

PHASE2RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 10, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Hot Flashes
Interventions
DRUG

Fezolinetant

oral

DRUG

Placebo

oral

Trial Locations (27)

Unknown

RECRUITING

Beijing Hospital, Beijing

RECRUITING

Capital Medical University (CMU) - Beijing Shijitan Hospital, Beijing

RECRUITING

Capital Medical University - Beijing Obstetrics and Gynecology Hospital, Beijing

RECRUITING

Peking Union Medical College Hospital, Beijing

RECRUITING

Guangzhou Medical University - The Third Affiliated Hospital, Guangzhou

RECRUITING

Zhujiang Hospital of Southern Medical University, Guangzhou

RECRUITING

Peking University Shenzhen Hospital, Shenzhen

RECRUITING

Shenzhen Maternal & Child Health Hospital, Shenzhen

RECRUITING

Guangxi Medical University (GXMU) - Liuzhou Renmin Hospital, Liuzhou

RECRUITING

Liuzhou Worker's Hospital, Liuzhou

RECRUITING

Guangzhou Medical University - The Third Affiliated Hospital, Guangzhou

RECRUITING

Hainan Women and Children's Medical Center, Haikou

RECRUITING

The second Hospital of Hebei Medical University, Shijiazhuang

RECRUITING

Hunan Provincial Maternal and Child Health Care Hospital, Changsha

RECRUITING

Xiangya Hospital, Central South University, Zhuzhou

RECRUITING

Nanjing First Hospital, Nanjing

RECRUITING

Southeast University, ZhongDa Hospital, Nanjing

RECRUITING

Jiangxi Maternal and Child Health Hospital, Nanchang

RECRUITING

Jilin Province FAW General Hospital, Changchun

RECRUITING

Jinan Central Hospital Affiliated to Shandong First Medical University, Jinan

RECRUITING

Shandong Provincial Hospital, Jinan

RECRUITING

Shanghai First Maternity and Infant Hospital, Shanghai

RECRUITING

Shanxi Woman and Children Hospital, Taiyuan

RECRUITING

The First hospital of Shanxi Medical University, Taiyuan

RECRUITING

Chengdu Women's and Children's Central Hospital, Chengdu

RECRUITING

The Second Hospital of Tianjin Medical University, Tianjin

RECRUITING

Hangzhou First People's Hospital, Hangzhou

All Listed Sponsors
lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT06812754 - A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through Menopause | Biotech Hunter | Biotech Hunter